Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Am. J. Epidemiol.
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Duclos, P.
Right arrow Articles by Olivé, J.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duclos, P.
Right arrow Articles by Olivé, J.-M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 155, No. 10 : 897-898
Copyright © 2002 by The Johns Hopkins University School of Hygiene and Public Health

ORIGINAL CONTRIBUTIONS

Invited Commentary: Pertussis, A Forgotten Killer

Philippe Duclos and Jean-Marc Olivé

From the Department of Vaccines and Biologicals, Health Technology and Pharmaceuticals, World Health Organization, 20 Avenue Appia, CH-1211 Geneva 27, Switzerland (e-mail: duclosp@who.int).

Abbreviations: DPT, diphtheria-tetanus-pertussis; WHO, World Health Organization


   INTRODUCTION
 
Pertussis remains one of the major causes of childhood morbidity and mortality at the global level. Widespread immunization coverage with diphtheria-tetanus-pertussis (DTP) vaccines is the cornerstone of prevention. However, with the lack of a specific global disease reduction target and although coverage with three doses of DTP vaccine is a major indicator of immunization programs (1Go), pertussis has not received sufficient emphasis in recent years. This is despite the annual global occurrence of millions of cases, with an estimated 296,000 remaining deaths (2Go), and the wide availability of effective vaccines (3Go). Yet pertussis surveillance is difficult, and disease burden due to this pertussis goes largely unrecognized. To raise the profile of pertussis, more effective surveillance tools are needed, particularly in developing countries, if the disease is to come under control.

A meeting on pertussis surveillance was organized on October 16–18, 2000, under the aegis of the World . . . [Full Text of this Article]


   NOTES
 

   REFERENCES
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Am. J. Epidemiol.:

Epidemiology of Pertussis in a West African Community before and after Introduction of a Widespread Vaccination Program
Marie-Pierre Préziosi, Abdoulaye Yam, Steven G. F. Wassilak, Laurence Chabirand, Aminata Simaga, Malick Ndiaye, Marème Dia, François Dabis, and François Simondon
Am. J. Epidemiol. 2002 155: 891-896. [Abstract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 PediatricsHome page
N. Le Saux, N. J. Barrowman, D. L. Moore, S. Whiting, D. Scheifele, S. Halperin, and for Members of the Canadian Paediatric Society/ He
Decrease in Hospital Admissions for Febrile Seizures and Reports of Hypotonic-Hyporesponsive Episodes Presenting to Hospital Emergency Departments Since Switching to Acellular Pertussis Vaccine in Canada: A Report From IMPACT
Pediatrics, November 1, 2003; 112(5): e348 - 348.
[Abstract] [Full Text] [PDF]

Home page
 JWatch Infect. DiseasesHome page
Pertussis -- An Effective Vaccination Program
Journal Watch Infectious Diseases, June 21, 2002; 2002(621): 2 - 2.
[Full Text]